Celgene Corporation Second Quarter 2005 Earnings Conference Call.

SUMMIT, N.J. -- Celgene Celgene Corporation NASDAQ: CELG is a manufacturer of drug therapies for cancer and inflammatory disorders. It is incorporated in Delaware and headquartered in Summit, New Jersey. Corporation (NASDAQ NASDAQ
in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CELG) will announce second quarter operational and financial results on Thursday, July 28, 2005. Celgene's management team will host a conference call and live audio webcast to discuss the financial and operational results.

The webcast will be available in the investor relations Investor relations

The process by which the corporation communicates with its investors. sections of the Company's website at www.celgene.com and will be archived for two weeks.

The webcast is also being distributed through the Thomson StreetEvents Network to both institutional and individual investors. Individual investors can listen to the call at www.fulldisclosure.com, Thomson/CCBN's individual investor portal, powered by StreetEvents. Institutional investors Institutional Investor

A non-bank person or organization that trades securities in large enough share quantities or dollar amounts that they qualify for preferential treatment and lower commissions. can access the call via Thomson's password-protected event management site, StreetEvents (www.streetevents.com).

Celgene Corporation, headquartered in Summit, New Jersey, is an integrated global biopharmaceutical company engaged primarily in the discovery, development and commercialization of novel therapies for the treatment of cancer and inflammatory diseases Noun 1. inflammatory disease - a disease characterized by inflammation
disease - an impairment of health or a condition of abnormal functioning

NEC, necrotizing enterocolitis - an acute inflammatory disease occurring in the intestines of premature infants; through gene and protein regulation. For more information, please visit the Company's website at www.celgene.com.

COPYRIGHT 2005 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.

Reader Opinion

Article Details
Printer friendly Cite/link Email Feedback
Publication:	Business Wire
Geographic Code:	1USA
Date:	Jul 18, 2005
Words:	165
Previous Article:	Schaeffer's Daily Market Blog Features Google, Cyberonics, Cisco Systems, Hasbro, and Mattel.
Next Article:	Southern Union to Report 2Q Earnings and Host Investor Call/Webcast on August 9.
Topics:	Pharmaceutical industry

Related Articles
Celgene Corporation Will Announce Second Quarter Financial Results on July 25, 2002.
Celgene Corporation Will Announce Third Quarter Financial Results on October 24, 2002.
Celgene Corporation Will Announce Fourth Quarter and Full Year Financial Results on January 30, 2003.
Celgene Corporation Will Announce First Quarter Financial Results on April 24, 2003.
Celgene Corporation to Announce Third Quarter Financial and Operational Results on October 23, 2003.
Celgene Corporation to Announce Fourth Quarter and Year-End 2003 Financial and Operational Results on January 29, 2004.
Celgene Corporation to Announce First Quarter Financial and Operational Results on April 22, 2004.
Celgene Corporation to Announce Second Quarter Financial and Operational Results on July 22, 2004.
Celgene Corporation Third Quarter 2004 Earnings Conference Call.
Rely on the analysis: Tedd Alexander or Credo Capital Management thoroughly scrutinizes financial fundamentals.